Tumor-derived MMPs regulate cachexia in a Drosophila cancer model

Area of Science:

• Oncology
• Molecular Biology
• Developmental Biology

Background:

• Cachexia, a wasting syndrome, contributes significantly to cancer-related deaths.
• Understanding the molecular mechanisms of cachexia is crucial for developing effective treatments.

Purpose of the Study:

• To establish and utilize a Drosophila larval model to investigate the mechanisms of cancer-induced organ wasting.
• To identify key molecular mediators responsible for cachexia.

Main Methods:

• Developed a Drosophila larval model with epithelial overgrowth in eye-antennal discs.
• Analyzed fat-body remodeling and muscle wasting.
• Investigated the role of tumor-secreted matrix metalloproteinase 1 (Mmp1).
• Assessed the impact of Mmp1 on TGFβ signaling and basement membrane/extracellular matrix (BM/ECM) proteins.
• Utilized a QF2-QUAS binary expression system to inhibit TGFβ signaling or Mmps.

Main Results:

• Tumor-induced epithelial overgrowth led to adipose tissue and muscle wasting.
• Wasting was dependent on tumor-secreted Mmp1.
• Mmp1 modulated TGFβ signaling and disrupted BM/ECM protein localization in fat body and muscle.
• Inhibition of TGFβ signaling or Mmps rescued muscle wasting.

Conclusions:

• Tumor-derived matrix metalloproteinases (MMPs) are central mediators of organ wasting in cancer cachexia.
• Targeting MMPs or TGFβ signaling presents a potential therapeutic strategy for cachexia.